NABL Accredited
Detection of Fetal Aneuploidies (13, 18, 21 and XY) by QF PCR and Chromosomal Array CGH, POC
Sample Collection & Prep:
POC - 1)Upto 12 weeks of gestation: 50-100 mg placental villi (fetal side) in 20 ml normal saline with 2-3 drops of gentamycin in a
Specimen Type:
Blood (Serum)
Testing Methodology:
Array Comparative Genomic Hybridization (Array CGH) 20-30 MG
Testing Schedule:
Mon–Sat 9th Day : 6:00 PM
Report Delivery:
Within 9th day via WhatsApp & Email
Fasting Requirement:
No strict fasting required before sample collection
Quality Standard:
100% NABL Accredited clinical reference laboratory testing
₹18000
Test Information
Preparation requirements and diagnostic clinical parameters.
Parameters
1 Parameter- 1 diagnostic parameter
- Automated calibrated clinical analyzer
Fasting & Prep
No Fasting- No strict fasting required
- Plain drinking water intake permitted
Specimen
Blood (Serum)- Matrix: Blood (Serum)
- Prep: POC - 1)Upto 12 weeks of gestation: 50-100 mg placental villi (fetal side) in 20 ml normal saline with 2-3 drops of gentamycin in a
Turnaround
9th day- Report in Mon–Sat 9th Day : 6:00 PM
- Verified PDF via WhatsApp & Email
Detection of Fetal Aneuploidies (13, 18, 21 and XY) by QF PCR and Chromosomal Array CGH, POC
1 parameter across 1 body system
Genetics & Molecular Diagnostics Profile
Clinical laboratory investigation processed on automated diagnostic analyzers.
1 Parameter
Detection of Fetal Aneuploidies (13, 18, 21 and XY) by QF PCR and Chromosomal Array CGH, POC
Detection of Fetal Aneuploidies (13, 18, 21 and XY) by QF PCR and Chromosomal Array CGH, POC
